SGC0946
SGC0946 is a selective DOT1L inhibitor with an IC50 value of 0.3 nM. By inhibiting DOT1L, SGC0946 can induce G1 phase arrest, suppress cell self-renewal and metastatic potential, and induce cell differentiation in cancer cells. SGC0946 can be used in the research of tumors such as leukemia and breast cancer, and also serves as a probe to further investigate the cellular mechanisms of DOT1L in normal and diseased cells[1][2][3].
Product Specifications
CAS Number
1561178-17-3
UNSPSC
12352005
Hazard Statement
H301
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/SGC0946.html
Purity
99.68
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CC(C)(C1=CC=C(C=C1)NC(NCCCN(C[C@@H]2[C@@H](O)[C@@H](O)[C@H](N3C4=C(C(Br)=C3)C(N)=NC=N4)O2)C(C)C)=O)C
Molecular Formula
C28H40BrN7O4
Molecular Weight
618.57
Precautions
H301
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
DOT1L
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Tert-Butyl 4- (2,2-difluoroethyl) piperazine-1-carboxylate
Tert-Butyl 4- (2,2-difluoroethyl) piperazine-1-carboxylate
